Hong Kong stocks end over 1% lower as financials, Mengniu weigh

* Hang Seng index ends down 1.28%

* China Enterprises index HSCE falls 1.04%

* HSI financial sub-index is down 2%; property sector slips 0.6%

HONG KONG, May 3 (Reuters) - Hong Kong stocks fell on Monday, due to profit-booking after a recent rally in subdued trading as the Chinese markets were closed for holidays, while rising COVID-19 cases in the region raised concerns of more measures and deeper economic pain.

** The Hang Seng index .HSI closed down 367.34 points, or 1.28%, at 28,357.54, its lowest closing since March 29. The Hang Seng China Enterprises index .HSCE fell 1.04% to 10,713.

** After identifying a cluster of COVID-19 cases over the weekend, Singapore tightened social distancing controls.

** The Hong Kong Monetary Authority, the key manager of Hong Kong's Exchange Fund, said slow vaccination take up in the city could hinder its competitiveness as a business centre.

** The sub-index of the Hang Seng tracking energy shares .HSCIE dipped 0.1%, while IT .HSCIIT , financials .HSNF and property .HSNP sectors ended 0.53%, 2.04% and 0.57% lower, respectively.

** China's stock and bond markets, as well as its foreign exchange and commodity futures markets are closed on May 1-5 for the Labour Day holiday.

** "Investors were not even interested in hunting for bargain when markets like Japan and China were on holiday," said Steven Leung, a sales director at UOB Kay Hian, adding, concern over further measures from China's regulators aiming at new economy stocks also kept investors away.

** The top gainer on the Hang Seng was China Petroleum & Chemical Corp 0386.HK , up 1.29%, while the biggest loser was China Mengniu Dairy Co Ltd 2319.HK , dropping 3.49%.

** Around the region, MSCI's Asia ex-Japan stock index .MIAPJ0000PUS was weaker by 0.73%

** The top gainers among H-shares were Anhui Conch Cement Co Ltd 0914.HK up 1.94%, followed by Hansoh Pharmaceutical Group Company Ltd 3692.HK , gaining 1.49% and Postal Savings Bank of China Co Ltd 1658.HK , up by 1.38%.

** The three biggest H-shares percentage decliners were China Mengniu Dairy Co Ltd 2319.HK , down 3.49%, China Feihe Ltd 6186.HK , falling 2.93% and Alibaba Health Information Technology Ltd 0241.HK , down 2.53%.
Reporting by Donny Kwok; Editing by Rashmi Aich

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.